Sun Pharmaceutical Industries Reflects Broader Market Trends Amid Recent Challenges
Sun Pharmaceutical Industries is trading at Rs 1,640, maintaining its opening price. The company has a market capitalization of Rs 3,93,310.98 crore and a P/E ratio of 34.25. While it has faced short-term declines, it has shown significant long-term growth, outperforming the Sensex over five years.
Sun Pharmaceutical Industries has shown notable activity today, trading at Rs 1,640, consistent with its opening price. The stock's performance aligns with the broader sector, reflecting a -0.11% change for the day, slightly better than the Sensex's -0.15%. In terms of market metrics, Sun Pharma holds a market capitalization of Rs 3,93,310.98 crore, categorizing it as a large-cap company. The stock's price-to-earnings (P/E) ratio stands at 34.25, which is slightly below the industry average of 35.67.
Over the past year, Sun Pharmaceutical Industries has experienced a decline of 4.69%, contrasting with the Sensex's positive performance of 2.72%. The stock has faced challenges in the short term, with a 10.67% drop over the last three months, while the Sensex has remained relatively stable with a slight increase of 0.13%.
Despite these recent struggles, Sun Pharma has demonstrated resilience over the longer term, boasting a 209.88% increase over the past five years, significantly outperforming the Sensex's 114.79% growth in the same period.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
